$0.00
(+0.00%
) Quote detailsUSD
+$0.00
(+0.00%
)At Close (As of Nov 28, 2025)
$702.87M
Market Cap
-
P/E Ratio
-2.5
EPS
$10.38
52 Week High
$1.45
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Lexeo Therapeutics, Inc. is a New York-based clinical-stage genetic medicine company dedicated to developing pioneering therapies for hereditary and acquired diseases. Leveraging advanced gene-editing technologies, Lexeo is advancing a robust and diverse pipeline of innovative treatments aimed at addressing significant unmet medical needs and enhancing patient outcomes. With a strong commitment to proprietary platform development, Lexeo is well-positioned to make a substantial impact in the burgeoning field of genetic medicine, representing a compelling opportunity for institutional investors interested in transformative healthcare solutions.
LPTX
VHAI
KTTA
NVDA
HBI
TLRY
INTC
BITF
IPG
BYND
CLSK
ADAP
ASST
PLUG
SNAP
AAL
BIYA
TSLA
CIFR
IVP
MARA
WULF
NIO
GOOG
F
NFLX
MTSR
SOFI
VALE
GOOGL
BTBT
ADTX
DVLT
GRAB
PFE
CAN
APLD
DNN
BABA
IBRX
RIOT
MSTR
WBD
AG
IREN
RIG
BAC
AMD
SMR
WMT
TMC
PLTR
CDE
ITUB
AGNC
KDLY
T
AMC
NVO
META
SAND
LPTX
VHAI
KTTA
NVDA
HBI
TLRY
INTC
BITF
IPG
BYND
CLSK
ADAP
ASST
PLUG
SNAP
AAL
BIYA
TSLA
CIFR
IVP
MARA
WULF
NIO
GOOG
F
NFLX
MTSR
SOFI
VALE
GOOGL
BTBT
ADTX
DVLT
GRAB
PFE
CAN
APLD
DNN
BABA
IBRX
RIOT
MSTR
WBD
AG
IREN
RIG
BAC
AMD
SMR
WMT
TMC
PLTR
CDE
ITUB
AGNC
KDLY
T
AMC
NVO
META
SAND